Your browser doesn't support javascript.
loading
Exploring the UDP pocket of LpxC through amino acid analogs.
Hale, Michael R; Hill, Pamela; Lahiri, Sushmita; Miller, Matthew D; Ross, Philip; Alm, Richard; Gao, Ning; Kutschke, Amy; Johnstone, Michele; Prince, Bryan; Thresher, Jason; Yang, Wei.
  • Hale MR; Infection Innovative Medicines Unit, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, USA. michael.hale@astrazeneca.com
Bioorg Med Chem Lett ; 23(8): 2362-7, 2013 Apr 15.
Article en En | MEDLINE | ID: mdl-23499237
ABSTRACT
Lipopolysaccharide (LPS) biosynthesis is an attractive antibacterial target as it is both conserved and essential for the survival of key pathogenic bacteria. Lipid A is the hydrophobic anchor for LPS and a key structural component of the outer membrane of Gram-negative bacteria. Lipid A biosynthesis is performed in part by a unique zinc dependent metalloamidase, LpxC (UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase), which catalyzes the first non-reversible step in lipid A biosynthesis. The UDP portion of the LpxC substrate-binding pocket has been relatively unexplored. We have designed and evaluated a series of hydroxamate based inhibitors which explore the SAR of substitutions directed into the UDP pocket with a range of substituted α-amino acid based linkers. We also provide the first wild type structure of Pseudomonas aeruginosa LpxC which was utilized in the design of many of these analogs.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Uridina Difosfato / Amidohidrolasas / Aminoácidos Cíclicos Idioma: En Año: 2013 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Uridina Difosfato / Amidohidrolasas / Aminoácidos Cíclicos Idioma: En Año: 2013 Tipo del documento: Article